PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2-methyl-1-nitropropane | 830-037-5 | 625-74-1 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyl-2,3,4,5,6,7,8,9,10,11,12,13-dodecahydro-1H-cyclopenta[12]annulene | 606-858-8 | 21890-09-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-Methyl-2-nitropropane-15N | 685-812-9 | 74228-29-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyl-3-butenenitrile | 240-596-1 | 16529-56-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyl-4-phenyl-1,3-dioxolane | 251-752-3 | 33941-99-0 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-Methyl-5-phenylpentanal | 455-570-7 | 36613-11-3 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyl-5-propylcyclohex-2-en-1-one | 807-489-7 | 1447712-18-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyl-m-phenylene diisocyanate | 202-039-0 | 91-08-7 | - | - | 1 | - | 3 | - | - | - | - | Details |
| 2-methylaminoethanol | 203-710-0 | 109-83-1 | - | - | 2 | - | - | - | - | - | - | Details |
| 2-methylanisole | 209-426-3 | 578-58-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylbut-2-ene | 208-156-3 | 513-35-9 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-methylbut-3-yn-2-ol | 204-070-5 | 115-19-5 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-methylbutane | 201-142-8 | 78-78-4 | - | - | 2 | - | - | - | - | - | - | Details |
| 2-methylbutyl acrylate | 256-170-3 | 44914-03-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 2-methylbutyl salicylate | 256-972-3 | 51115-63-0 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylbutyric acid | 204-145-2 | 116-53-0 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylbutyronitrile | 242-687-1 | 18936-17-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylcyclohexanol, mixed isomers | 209-512-0 | 583-59-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylcyclohexanone | 209-513-6 | 583-60-8 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylcyclopentane-1,3-dione | 212-153-2 | 765-69-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methylcyclopentanone | 214-318-4 | 1120-72-5 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-methyldecanenitrile | 273-960-3 | 69300-15-8 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 2-methylglutaric acid | 210-521-7 | 617-62-9 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-methylglutaronitrile | 224-923-5 | 4553-62-2 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-Methyloctane-1,8-diamine | 700-111-0 | 148528-05-6 | - | - | 1 | - | 1 | - | - | - | - | Details |